Sagimet Biosciences
SGMT
SGMT
66 hedge funds and large institutions have $78.8M invested in Sagimet Biosciences in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
78% less call options, than puts
Call options by funds: $281K | Put options by funds: $1.26M
Holders
66
Holding in Top 10
2
Calls
$281K
Puts
$1.26M
Top Buyers
| 1 | +$2.25M | |
| 2 | +$864K | |
| 3 | +$622K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$386K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$376K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$2.12M | |
| 3 | -$1.93M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.69M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
-$1.57M |